Pacira BioSciences appoints Shawn Cross as CFO effective Oct 21, 2024

Pacira BioSciences, Inc.

Shawn Cross appointed CFO effective Oct 21, 2024; succeeds interim CFO Lauren Riker, who remains SVP of Finance.
Cross brings >25 years of biopharma experience; former CEO/President/CFO of Applied Molecular Transport.
Annual base salary $525K; annual bonus target 50% of base; inducement awards of 200K stock options and 75K RSUs.
Inducement awards vest over four years; option exercise price equals Nov 4, 2024 closing price.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Lauren Riker

Senior Vice President of Finance

PCRX · Pacira BioSciences, Inc.

Effective: 2024-10-21
Successor: Shawn M. Cross
Filed: October 21, 2024, 7:59 PM ET

Mr. Cross will succeed Lauren Riker, who had been serving as interim Chief Financial Officer since October 1, 2024.

Appointed

Shawn M. Cross

Chief Financial Officer

PCRX · Pacira BioSciences, Inc.

Effective: 2024-10-21
Filed: October 21, 2024, 7:59 PM ET

appointed Shawn M. Cross to serve as the Chief Financial Officer of the Company, effective October 21, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Lauren Riker changed role as Senior Vice President of Finance at Pacira BioSciences, Inc..

Action: succeeded
Role: Senior Vice President of Finance

Exact text from the filing

Mr. Cross will succeed Lauren Riker, who had been serving as interim Chief Financial Officer since October 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Shawn M. Cross was appointed as Chief Financial Officer at Pacira BioSciences, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

appointed Shawn M. Cross to serve as the Chief Financial Officer of the Company, effective October 21, 2024.

View on SEC.gov

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-24-000129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.